It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MIRA’s FA Score shows that 0 FA rating(s) are green whileOGN’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MIRA’s TA Score shows that 5 TA indicator(s) are bullish while OGN’s TA Score has 5 bullish TA indicator(s).
MIRA (@Pharmaceuticals: Major) experienced а +8.70% price change this week, while OGN (@Pharmaceuticals: Major) price change was +2.60% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.35%. For the same industry, the average monthly price growth was +5.72%, and the average quarterly price growth was +12.95%.
MIRA is expected to report earnings on Sep 03, 2025.
OGN is expected to report earnings on Oct 30, 2025.
The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
MIRA | OGN | MIRA / OGN | |
Capitalization | 27.7M | 2.45B | 1% |
EBITDA | -8.06M | N/A | - |
Gain YTD | 31.579 | -35.278 | -90% |
P/E Ratio | N/A | 3.51 | - |
Revenue | 0 | N/A | - |
Total Cash | 1.21M | N/A | - |
Total Debt | 0 | 8.96B | - |
MIRA | OGN | |
---|---|---|
RSI ODDS (%) | 3 days ago90% | 3 days ago64% |
Stochastic ODDS (%) | 3 days ago90% | 3 days ago65% |
Momentum ODDS (%) | 3 days ago90% | 3 days ago69% |
MACD ODDS (%) | 3 days ago90% | 3 days ago74% |
TrendWeek ODDS (%) | 3 days ago86% | 3 days ago67% |
TrendMonth ODDS (%) | 3 days ago89% | 3 days ago70% |
Advances ODDS (%) | 5 days ago88% | 3 days ago68% |
Declines ODDS (%) | 11 days ago90% | 18 days ago73% |
BollingerBands ODDS (%) | 3 days ago90% | 3 days ago65% |
Aroon ODDS (%) | 7 days ago90% | 3 days ago77% |
A.I.dvisor tells us that MIRA and AMRN have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIRA and AMRN's prices will move in lockstep.
Ticker / NAME | Correlation To MIRA | 1D Price Change % | ||
---|---|---|---|---|
MIRA | 100% | +2.04% | ||
AMRN - MIRA | 20% Poorly correlated | +4.06% | ||
VRBCF - MIRA | 14% Poorly correlated | N/A | ||
OGN - MIRA | 12% Poorly correlated | +0.75% | ||
SCLX - MIRA | 8% Poorly correlated | +4.09% | ||
GRFS - MIRA | 8% Poorly correlated | -0.19% | ||
More |
A.I.dvisor indicates that over the last year, OGN has been loosely correlated with PFE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then PFE could also see price increases.